Skip to content

menu

Pharma in Brief logo
HomeAboutContact
Search
Close
Pharmaceuticals and life sciencesIntellectual propertyLife sciences and healthcare
View topics Archives
Subscribe

Pharma in Brief

Regulatory

Subscribe to Regulatory via RSS

COVID-19: Health Canada Issues Bulletin Confirming Obligations of DEL Holders

Photo of Randy SuttonPhoto of John Greiss
By Randy Sutton & John Greiss on March 5, 2020

In light of recent developments relating to the to the 2019 novel coronavirus (COVID-19), Health Canada recently sent a reminder to all Drug Establishment License (DEL) holders of their obligations under the Food and Drug Regulations (FDR) regarding reporting of…

Ontario reduces restrictions on ordinary commercial term benefits and private label products

Photo of Randy SuttonPhoto of William Chalmers
By Randy Sutton & William Chalmers on December 17, 2019

The Ontario Ministry of Health and Long-Term Care (the Ministry) introduced changes to regulations (collectively, the Regulations) made under the Ontario Drug Benefit Act (ODBA) and the Drug Interchangeability and Dispensing Fee Act (DIDFA).…

Ontario consults on changes to streamline drug formulary listing and reduce government payments to pharmacies

Photo of Kristin WallPhoto of William Chalmers
By Kristin Wall & William Chalmers on November 10, 2019

The Ontario Ministry of Health and Long-Term Care (the Ministry) has proposed draft amendments to Regulations made under the Ontario Drug Benefit Act (ODBA) and the Ontario Drug Interchangeability and Dispensing Fee Act. The proposed changes…

Post navigation

 Newer Posts

Pharma in Brief

LinkedIn Twitter Facebook RSS YouTube
Published by
Norton Rose Fulbright LLP logo
DisclaimerPrivacy policy

About

Stay up-to-date with legal and regulatory developments affecting the pharmaceutical industry. Pharma in Brief provides timely updates with a focus on the key take-away you need to know.

Read more

Topics

Archives

Copyright © 2025, Norton Rose Fulbright LLP. All rights reserved.